MSM Vaccines PR = MSM Vaccines Owners (Zuckerman and Murdoch)
Mort Zuckerman
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, dpr...@stmartin.edu
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com,
bob.d...@latimes.com
Subject: MSM Vaccines PR = MSM Vaccines Owners
Date: Oct 27, 2009 5:39 AM
ARTICLE BELOW
===========================
The article below talks about Mort Zuckerman's
backing of the phony non-profit, the ALDF.com,
http://www.actionlyme.org/ALDF_BOARD.htm
and how LYMErix gave people Chronic Neurologic
Lyme-like symptoms, proving the key to
the real mechanisms of illness, Pam3Cys
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=19025640&ordinalpos=1&log$=relatedarticles&logdbfrom=pubmed
also found in the failed Tuberculosis
and failed HIV vaccines (and cancer, BTW;
Joe Tully)
http://www.actionlyme.org/FUNGAL_VACCINES.htm
A lot of people think these vaccines
are meant to weaken people's immune
systems after which we wait for the BIG
ONE, which will knock out even more people.
If that was the intention all along, these
crooks could not have come up with a better
one than PamCys, but at the same time, what
Pam3Cys does, does not jive with what the
crooks say is even a "disease:"
http://www.geocities.com/kmdickson0308/lyme-dilemma.html
Sigal and Shapiro, lying their eyeballs
out on a PBS show:
http://www.geocities.com/kmdickson0308/1-4.txt
In 1992, the CDC knew the current case definition
only fit a small percentage of people, those
with Steere's HLA:
http://v3.espacenet.com/publicationDetails/description?CC=AU&NR=4392093A&KC=A&FT=D&date=19931230&DB=EPODOC&locale=
"Summarv of the Invention
In one aspect, the invention provides isolated B. burgdorferi antigens
which are regulated and differentiated by growth of the B. burgdorferi
in a tick vector. Novel antigens of the invention are listed below in
Table I.
"***Certain of these antigens are characterized as being B.
burgdorferi B31 strain specific and major histocompatibility complex
(MHC) nonrestricted. Certain other of these antigens are characterized
as being MHC restricted.*** Sera generated to these antigens (B31 MHC
nonrestricted and B31 MHC restricted) are further characterized by the
ability or lack of ability to react with B. burgdorferi JD-1 strain;
the antigens themselves (B31 MHC nonrestricted and B31 MHC restricted)
are further characterized by being homologous or heterologous with B.
burgdorferi JD-1 strain antigens. The most preferred antigens of this
invention, because of their ability to induce cross-strain immunity to
B. burgdorferi in different animal haplotypes, are characterized by
being B31 MHC nonrestricted, JD-1 crossreactive, and JD-1
nonrestricted.Other antigens are also useful in vaccine compositions
and as diagnostics."
Steere's HLA:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2078208[uid]
"CONCLUSIONS. Particular Class II major histocompatibility genes
determine a host immune response to B. burgdorferi that results in
chronic arthritis and lack of response to antibiotic therapy."
This ^^^ is something you can *see* in the
RICO complaint graphics:
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
On the right, the hypersensitivity reaction
of bound HLA-antigen complex, creating
too-many-antibodies. On the left is the
rest of us, who never test positive to the
now, current, CDC "case definition" of HLA-linked
too-many-antibodies.
CONCLUSION: CDC knew their standard to diagnose
a "case" of "Lyme Disease" was false.
CDC's staff's own 1992 patents that show it.
Now: Does anyone believe the CDC or the
NIH is competent to be calling "vaccines"
and "diseases?"
For further proof, go ahead and try to
find a published study of MMR vaccines
outcomes that goes beyond a month. All
those reports are even worse (less scientific)
than the SmithKline LYMErix report:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
THEY'RE WORSE!!!
So, I don't believe anybody. Except the
murdered Don C. Wiley, who said the pandemic
flu is likeliest to be a swine flu, due to
the requirement of a lesser mutation to
adapt to human receptors (not H1N1).
And the fact that he was murdered.
I could be wrong, of course, but I absolutely
never believe a single thing the CDC says. I
will immediately look at every CDC's statement's
converse to see if the scientific data, in fact,
supports that opposite.
Here are 5 European patents owned by CDC
staff, which all say the same thing:
http://v3.espacenet.com/inpadoc?submitted=true&DB=EPODOC&CC=WO&NR=9324145&KC=&F=8&OREQ=0&textdoc=TRUE&FT=E
"Only Steere's HLA folks will test positive
to the CDC's case definition standard."
Now, why does the NIH insist that Lyme is
only a hypersensitivity response, while
Anthony Fauci owns a patent for the treatment
of immune suppression outcomes of infections?
"FIELD OF THE INVENTION
"The present invention pertains to a method for activating the immune
system of a patient by intermittently administering interleukin-2
(IL-2) to that patient. Such administration of IL-2 can optionally be
combined with other therapies, such as anti-retroviral, anti-bacterial
or anti-fungal therapies, suitable for treatment of the patient's
condition. This invention also relates to an approach to gene therapy
that entails administering IL-2 to a patient so as to facilitate in
situ lymphocyte transduction by a retroviral vector also administered
to the patient.
"BACKGROUND OF THE INVENTION
"***Attempts at immune activation and restoration in the past have
utilized bone marrow transplantation or lymphocyte transfers (H. C.
Lane et al., Ann. Internal Med. 113:512-19 (1990)), immunomodulating
agents such as immuthiol (J. M. Lang et al., Lancet 24:702-06 (1988))
or isoprinosine (C. Pedersen et al., N. Engl. J. Med. 322: 1757-63
(1990)), and recombinant cytokines such as interferon alpha
(IFN-.alpha.) and IL-2. H. C. Lane et al., Ann. Intern. Med.
112:805-11 (1990); H. C. Lane et al., J. Biol. Response Mod. 3, 512-16
(1984); D. H. Schwartz et al., J. Acquir. Immune Defic. Syndr. 4,
11-23 (1991); P. Mazza et al., Eur. J. Haematol. 49:1-6 (1992); H. W.
Murray et al., Am. J. Med. 93:234 (1992); H. Teppler et al., J.
Infect. Dis. 167:291-98 (1993); P. Volberding et al., AIDS Res. Hum.
Retroviruses 3:115-24 (1987). These studies have resulted in minimal
or only transient immune system restoration.
"The use of biologic response modifiers in general, and of IL-2 in
particular, is an active area of clinical research. Interleukin-2 is a
T cell-derived lymphokine with a number of immunomodulating effects
including activation, as well as induction of proliferation and
differentiation, of both T and B lymphocytes. K. A. Smith, Science
140:1169-76 (1988). ***Exogenous IL-2 has been shown in vitro to
increase the depressed natural killer cell activity and
cytomegalovirus-specific cytotoxicity of peripheral blood mononuclear
cells from patients with AIDS, as well as to increase IFN-.lambda.
production by lymphocytes from patients with AIDS.*** A. H. Rook et
al., J. Clin. Invest. 72:398-403 (1983); H. W. Murray et al., loc.
cit. 76:1959-64 (1985)."
It's a patented treatment for the immune suppression outcomes of Lyme
disease, which is a condition simultaneously denied by the head of the
National Institute of Allergy and Infectious Diseases- who owns this
patent.
YOU DECIDE.
Anthony Fauci is Edward McSweegan's NIAID
boss and neither of them have been fired yet:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=19025640&ordinalpos=1&log$=relatedarticles&logdbfrom=pubmed
'Tolerance to fungal antigens and
induction of Epstein-Barr Virus
replication...
... or, the induction of Cancer, MS,
and ALS:
http://www.actionlyme.org/Pam3Cys_Version15.htm
I don't believe a single word uttered
by the CDC.
KMDickson
http://www.actionlyme.org
http://www.relapsingfever.org
======================
http://www.naturalnews.com/z027336_swine_flu_health_propaganda.html
Profit Driven Swine Flu Propaganda - Pump Up the Volume - Part Four
by Evelyn Pringle, health freedom writer
(NaturalNews) This article is part four in a six-part series. Be sure
to read part three at http://www.naturalnews.com/027310_s...
Those in control of the mainstream media have joined together with
public health officials to provide the pharmaceutical industry with
the best swine flu promotional campaign that money can buy.
In an October 7, 2009, OpEd News article titled, "The Centers for
Disease Control: The Best Vaccination PR Firm Taxes Can Buy," the
makers of the documentaries, "Vaccine Nation," and "Autism: Made in
the USA," Richard Gale and Dr Gary Null wrote:
"If the flu season goes according to schedule, the vaccine industrial
complex will be poised to join Wall Street for record year rip-off
profits. We will also likely witness huge Pharma executive bonuses and
perhaps gold-plated toilets.
"Even if the CDC statisticians' crystal ball used to forecast rampant
swine flu infections turns into a complete bust -- which would only be
one more added to many other failed flu predictions back to 1976 -- it
will nevertheless be a very profitable failure as was the economic
collapse for the banking cartel."
"In the US, such profits could never be accomplished without a
dynamic, marketing initiative to convince Americans that vaccines will
keep them protected and alive," they point out.
"And what better public relations machine for the vaccine complex, and
all its supporters in health insurance and professional medical
institutions, than our very own Centers for Disease Control and the
Department of Health and Human Services?" they wrote.
The CDC is "formulating a $4.8 million multimedia campaign to
encourage people to get vaccinated and help alleviate concerns and
confusion, including radio and television public service
announcements, print ads, and messages delivered via Twitter, RSS
feeds and video podcasts on YouTube," according to the August 22, 2009
Washington Post.
Government health officials "are mobilizing to launch a massive swine
flu vaccination campaign this fall that is unprecedented in its scope
-- and in the potential for complications," the Post reported. "The
campaign aims to vaccinate at least half the country's population
within months."
The federal government "has spent close to $2 billion to buy up to 195
million doses of vaccine and adjuvant," according to the Post.
"The government is prepared to buy enough to vaccinate every person --
600 million doses all together -- if the pandemic or demand warrants
it," the report said. "That could increase the cost to $5 billion for
the vaccine alone."
"It would cost at least $9 billion to administer the vaccine to the
entire population, according to the Association of State and
Territorial Health Officials," the Post advised.
There is nothing free about the flu vaccination campaigns in the US.
Americans will end up footing the bill in one way or another, along
with the medical care for persons injured by the vaccine.
"As always with pandemic flus, taxpayers are footing the $1.5 billion
check for the 250 million swine flu vaccines that the government has
ordered so far and will be distributing free to doctors, pharmacies
and schools," ABC News pointed out on October 14, 2009.
"In addition," the report said, "Congress has set aside more than $10
billion this year to research flu viruses, monitor H1N1's progress and
educate the public about prevention."
On October 5, 2009, the Associated Press advised that the H1N1 vaccine
itself is free because the government bought it with your tax dollars.
"But providers can charge a small fee for administering it, usually
about $20. Regular flu shots tend to cost up to $35," the AP said.
Doctors are also set to profit greatly from administering the
vaccines. The American Medical Association, which publishes Current
Procedural Terminology (CPT), has even revised one CPT code and issued
another for use in billing for H1N1 vaccines.
The changes "will streamline the reporting and reimbursement procedure
for physicians and healthcare providers who are expected to administer
nearly 200 million doses of the H1N1 vaccine in the U.S.," the AMA
said in a statement.
Media as a PR Firm
"In too many ways, the mainstream media has become little more than a
corporate mouthpiece, whoring itself out to the highest bidder /
advertiser," warns Mike Adams, in the September 18, 2009, Natural News
report titled, "Ten Swine Flu Lies Told by the Mainstream Media."
The "distorted reporting on the swine flu vaccine has been one of the
greatest media frauds ever perpetrated," he says.
"The media has in every way contributed to the widespread ignorance of
the American people on the subject of vitamin D and natural immune-
boosting defenses that could reduce swine flu fatalities," Adams
points out.
"Rather than informing readers," he says, "the MSM has made it a point
to keep the people stupid, and in doing so, the media has failed its
only mission and betrayed the very audience it claims to serve."
Vested Interest in Spreading Swine Flu Propaganda
The media moguls controlling the MSM world-wide have a vested interest
in hyping the swine flu epidemic to boost sales of vaccines and
funding for the vaccine research industry.
Rupert Murdoch is a major shareholder, chairman and managing director
of News Corporation. News Corp was the world's second largest media
conglomerate, behind Walt Disney Company, as of 2008, and the world's
third largest in entertainment as of 2009, according to Wikipedia, the
online encyclopedia.
In late 2003, Murdoch acquired a 34 percent stake in Hughes
Electronics, the operator of Direct TV, the largest American satellite
TV system. In 2004, Murdoch announced that he was moving News Corp's
headquarters from Australia to the US.
According to the Columbia Journalism Review, News Corp owns Fox
Broadcasting Company and 27 Fox Television Stations in major cities
all over the country, in addition to many cable channels, including
the Fox News channel, and 20th Century Fox film companies and studios.
News Corp also owns the New York Post, the Wall Street Journal and Dow
Jones.
On February 2, 2009, GlaxoSmithKline announced the appointment of
James Murdoch, son of media mogul Rupert Murdoch, as a non-executive
director. Murdoch joined the company on May 20, 2009 and will also be
a member of Glaxo's Corporate Responsibility Committee.
Murdoch is Chairman and Chief Executive of News Corporation, Europe
and Asia, and "has direct responsibility for the strategic and
operational development of News Corporation's television, newspaper
and related digital assets in Europe, Asia and the Middle East," Glaxo
noted.
Murdoch is in charge of "News International, owner of four British
newspapers -- the Times, Sunday Times, Sun and News of the World,"
according to an article titled, "The Invisible Mogul: Meeting James
Murdoch," by Sophie Barker, in the spring 2009 issue of "Intelligent
Life Magazine."
"His TV channels reach 200m people across 60-odd countries," Barker
reports.
The Murdoch Children's Research Institute (MCRI) is the largest
research Institute in Australia specialising in child and adolescent
health. "Located on the campus of the Royal Children's Hospital,
Melbourne, it is affiliated with the University of Melbourne," its
website states.
Rupert Murdoch's mother, Dame Elisabeth Murdoch, is the widow of
Australian newspaper publisher, Sir Keith Murdoch. She married Keith
Murdoch, 23 years her senior, in 1928 and inherited the bulk of his
fortune when he died in 1952. She was appointed a Dame Commander of
the Order of the British Empire in 1963.
"It was through seed funding provided by Dame Elisabeth" in 1984, that
the MCRI went on "to become the largest and most prestigious child
health research centre in Australia," according to the February 7,
2009, Frankston Standard Leader.
Elisabeth is a life-governor of the Royal Women's Hospital and a
Patron of the Murdoch Children's Research Institute, according to the
Australian Women's Register.
In 2009, MCRI has "over 1100 researchers," the Leader reports. Rupert
Murdoch's daughter-in-law, Sarah Murdoch, has been the ambassador for
the MCRI and a member of the development board since 2000.
The MCRI has six research themes, including one for "Infection,
immunity and environment," with research conducted at the "Centre for
Clinical Research Excellence in Child and Adolescent Immunisation."
The CCRE is a joint MCRI, Melbourne University, and Menzies School of
Health Research collaboration whose secretariat is located in the
Department of General Medicine at the Royal Children's Hospital
campus.
"Research focuses on clinical trials of new vaccines in healthy
infants, children and adolescents, the epidemiology of vaccine
preventable diseases (VPDs) and evaluation of the impact of population-
delivered vaccine programs, and mathematical modelling of vaccine-
preventable diseases," the MCRI website advises.
Under "Collaborations," the site lists: "Promotion of collaborations
with Australian and overseas immunisation researchers, policy-makers,
service providers and the vaccine industry."
Under a heading titled, "Commercialisation," the website states: "The
Murdoch Children's Research Institute invites interested parties to
take up the opportunity to invest in its wide portfolio of commercial
biotechnologies."
In a July 27, 2009 press release, MCRI announced that children "are
being recruited for a pandemic H1N1 swine flu vaccine trial set to
begin in Melbourne next week."
"About 100 Victorian children aged between 6 months to eight years are
needed for the study, which will be run by the Murdoch Childrens
Research Institute and the University of Melbourne from as early as
next week," the press release stated.
"They will be among 400 children recruited across five states for the
Federal Government required trials of the vaccine, produced by
Australian biopharmaceutical company CSL," it advised.
Four years ago, on October 4, 2005, the Murdoch Childrens Research
Institute issued a similar press release stating: "Bird flu vaccine
trial to begin."
"TRIALS of a bird flu vaccine are set to begin in Melbourne this week
as researchers prepare against the threat of an influenza pandemic,"
MCRI advised.
"The study, a collaborative project between the Murdoch Childrens
Research Institute and University of Melbourne, is being sponsored by
Australian pharmaceutical company CSL Limited," the press release
stated.
Media mogul, Mortimer Zuckerman, also has a research center named
after him. On May 10, 2009, the New York Times reported that Zuckerman
had "pledged $100 million to Memorial Sloan-Kettering Cancer Center,
the largest donation in the hospital's history and one of the largest
ever given to an American medical center."
"Sloan-Kettering will name its new research center on the Upper East
Side for Mr. Zuckerman, the real estate developer and owner of The
Daily News and U.S. News & World Report," the Times noted.
"Zuckerman advances vaccine research and development at the Mortimer
B. Zuckerman Research Center in association with the Memorial Sloan-
Kettering Cancer Center and Rockefeller University," according to Dr
Leonard Horowitz, a Harvard-trained authority in vaccinations and
emerging diseases with a masters degree in public health, in a
September 30, 2009, report by Sherri Kane.
Zuckerman is also a leading financier of the American Lyme Disease
Foundation that heavily promoted GlaxoSmithKline's disastrous Lymerix
vaccine, Horowitz says.
"This vaccine was pulled from the market following hundreds-of-
thousands of reported cases of recipients suffering post-vaccination
symptoms of Lyme disease," he reports.
The great bird flu hoax serves as an excellent example of use of the
MSM to pump out fear mongering propaganda. On June 20, 2005, Zuckerman
wrote a commentary in US News and World Report titled, "A Nightmare
Scenario – H5N1 Pandemic," and stated:
"Should it develop certain genetic changes, international health
experts warn, bird flu could spark a global pandemic, infecting as
much of a quarter of the world's population and killing as many as 180
million to 360 million people--at least seven times the number of AIDS
deaths, all within a matter of weeks."
"In the worst previous catastrophic pandemic, in 1918, more than 20
million died from the Spanish flu," Zuckerman wrote.
"We must prioritize research money to develop a vaccine, expand the
production of flu vaccine, and stockpile antiviral medications," he
advised.
On December 8, 2005, Bloomberg ran an article with the headline, "Bird
Flu Pandemic May Cost U.S. Economy $675 Billion," in which Senate
Majority Leader Bill Frist was quoted as saying, "A pandemic of bird
flu in humans may cost the U.S. economy $675 billion, including lost
work time and disruptions in supply chains."
This time around, on October 14, 2009, ABC News reported that "the
Trust for America's Health, a Washington-based non-profit
organization, estimates that a severe pandemic could push down GDP by
more than 5 percent and cost Americans $683 billion."
"We're not seeing a pandemic that's this severe," says Jeff Levi,
director of the group. "We've dodged a lot of bullets."
Last but not least, Thomas H Glocer is the Chief Executive Officer of
the Thomson Reuters Corporation. On November 26, 2007, Merck announced
that Thomas Glocer, Chief Executive Officer, Reuters Group PLC, "will
join the Company's Board of Directors effective Nov. 27."
"Merck currently discovers, develops, manufactures and markets
vaccines and medicines to address unmet medical needs," the press
release stated.
As shown above, the mainstream media cannot be objective when
reporting on the swine flu because it is riddled with conflicts of
interest involving the vaccine industry.
This article series continues with part four, to be published
tomorrow...
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci